Borderline Personality Disorder Clinical Trial
— SiMaT-BOfficial title:
Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Borderline Personality Disorder (BPD)
| Verified date | May 2017 |
| Source | University Hospital, Toulouse |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Primary purpose : to assess the effect on neuropsychological tasks related to planning of 10
daily sessions of right dorsolateral prefrontal cortex with High-frequency repetitive
transcranial magnetic stimulation (rTMS) on borderline personality disorder (BPD) patients.
Hypothesis : BPD patients receiving 10 sessions of rTMS will have greater improvement in the
average number of move to achieve tasks of the Tower of London, than those receiving sham
rTMS.
| Status | Completed |
| Enrollment | 13 |
| Est. completion date | April 2012 |
| Est. primary completion date | March 2011 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 20 Years to 45 Years |
| Eligibility |
Inclusion Criteria: - 20 to 45 years old - Borderline Personality Disorder (Diagnostic Interview for Borderline Personality Disorder > 8) - psychiatric follow-up - righthander - informed consent - affiliated to medical insurance Exclusion Criteria: - bipolar disorder - substance use disorder - Major Depressive Disorder or Stress Post Traumatic Disorder - history of epilepsy - neurosurgery - cardiac pacemaker - lefthander - involuntary admission - participation in an other research - legal guardianship - poor mastery of french. |
| Country | Name | City | State |
|---|---|---|---|
| France | Lionel Cailhol | Toulouse | University Hospital Toulouse |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Toulouse |
France,
Cailhol L, Roussignol B, Klein R, Bousquet B, Simonetta-Moreau M, Schmitt L, Thalamas C, Tap G, Birmes P. Borderline personality disorder and rTMS: a pilot trial. Psychiatry Res. 2014 Apr 30;216(1):155-7. doi: 10.1016/j.psychres.2014.01.030. Epub 2014 Jan — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Tower of London | Inclusion, 15th day, 30th day and 3rd month | ||
| Secondary | Balloon Analog Risk Task | Inclusion, 15th day, 30th day and 3rd month | ||
| Secondary | Micro-World Test | Inclusion, 15th day and 3rd month | ||
| Secondary | Borderline Personality Disorder Severity Index | Pre-inclusion, 30th day and 3rd month | ||
| Secondary | Symptom Check List - 90 | Inclusion, 15th day, 30th day and 3rd month | ||
| Secondary | Barratt Impulsivity Scale | Inclusion and 3rd month | ||
| Secondary | Global Assessment Scale | Inclusion and 3rd month |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
| Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
| Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
| Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
| Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
| Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
| Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
| Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
| Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
| Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
| Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
| Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
| Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
| Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
| Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
| Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
| Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
| Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
| Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
| Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A |